CRO Clears Path For Success For Rosacea Trial With Enrollment Hurdles

Two large, parallel trials with 107 sites spread across the United States. Heavy competition for patients because of multiple competing treatments already on the market. And an advertising strategy that needed to attract more than 1,400 subjects fast enough to meet the sponsor’s aggressive schedule.

Those were just some of the challenges we faced when studying a topical drug to treat rosacea. And as with most complex problems, the strategy required a broad set of solutions and experience-based insights.